학술논문

Chimeric antigen receptor T cells engineered to recognize the P329G-mutated Fc part of effector-silenced tumor antigen-targeting human IgG1 antibodies enable modular targeting of solid tumors
Document Type
Journal
Source
JOURNAL FOR IMMUNOTHERAPY OF CANCER; JUL 2022, 10 7, pe005054 17p.
Subject
Language
English
ISSN
20511426